Vinca Roseus: An Extensive Review focused on Recent Studies

Pharmacy

The Apocynaceae family includes the important medicinal plant Vinca rosea, also called Madagascar periwinkle (syn. Catharanthus roseus). Vincristine and vinblastine, two of its valuable alkaloids, are well known for their strong anticancer properties and are used to treat leukemia, Hodgkin's lymphoma, and other cancers. Numerous pharmacological properties of vinca rosea include anti-inflammatory, anti-cancer, anti-hypertensive, and antioxidant properties. Both decorative and medicinal uses are pursued for this plant, which grows well in tropical and subtropical climates. Numerous studies in pharmacology and phytochemistry continue to emphasize Vinca rosea's significance as a source of bioactive compounds for contemporary medicine and drug development. The techniques employed to study Vinca roseus vary depending on the goal of the study; for instance, phytochemical screening, pharmacological assessment, or active compound extraction. All things considered, Vinca roseus is a great source of naturally occurring bioactive compounds and is still used extensively in drug development and pharmaceutical research. Its medicinal potential for future therapeutic use can be further unlocked with the aid of sustainable cultivation and additional research. Medicinal plants were a powerful source of many innovative pharmaceutical products that have a strong pharmacological impact on people. Ancient medicine could be investigated to find new drug formulations that are more cost-effective, have fewer side effects, and are more effective than chemical drugs that cause side effects.

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.